Related Experiment Video
Updated: Jul 30, 2026

11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
K-ras mutations in 239PuO2 canine lung neoplasms.
S M Griffey1, S A Kraegel, R E Weller
1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis 95616, USA.
Cancer Letters
|July 9, 1999
Summary
K-ras mutations were found in 8% of plutonium-exposed beagle lung tumors, a higher rate than previously seen in canine plutonium-induced cancers but lower than spontaneous lung cancers in dogs and humans.
Area of Science:
- Radiobiology
- Oncology
- Molecular Biology
Background:
- Plutonium dioxide (239PuO2) inhalation exposure is a known risk factor for lung cancer.
- Investigating genetic alterations in lung tumors can elucidate cancer development mechanisms.
Purpose of the Study:
- To identify mutations in the K-ras gene in lung tumors from beagle dogs exposed to 239PuO2.
- To compare the frequency of K-ras mutations in plutonium-induced lung tumors to other canine and human lung cancers.
Main Methods:
- Single-strand conformational polymorphism (SSCP) analysis and direct sequencing were employed.
- Tumor tissues from 25 beagle dogs with documented 239PuO2 inhalation exposure and subsequent lung tumors were analyzed.
- Exon 1 of the K-ras gene was specifically examined for mutations.
Main Results:
- Mutations in the K-ras gene were detected in 2 out of 25 (8%) plutonium-induced lung tumors.
- Both identified mutations were GGT to GAT transitions at codon 12.
- The mutation rate (8%) was higher than in previous studies of canine plutonium-induced lung tumors (0%) but lower than in spontaneous canine lung cancer (16%) and human non-small cell lung cancer (13-36%).
Conclusions:
- The K-ras gene is a potential target for mutations in plutonium-induced canine lung cancer.
- The observed mutation frequency suggests a role for K-ras in the pathogenesis of radiation-induced lung tumors.
- Further research is warranted to understand the full spectrum of genetic changes in plutonium-induced lung cancers.
Related Concept Videos
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

